Advertisement

Supplemental Material

The links to relevant recommendations of the American College of Obstetricians and Gynecologists are provided as the primary source of supplemental information to that provided in Clinical Updates in Women's Health Care monographs when applicable. The links to resources other than those of the American College of Obstetricians and Gynecologists are provided for information purposes only, and referral to these resources does not imply the endorsement of the American College of Obstetricians and Gynecologists.

Continuing Care for Women With Breast Cancer (Vol IX, No 2)

For further information on breast cancer refer to the following:

Recommendations for target populations for hereditary breast cancer screening
http://www.nccn.org

BI-RADS - mammography
http://www.acr.org/Quality-Safety/Resources/BIRADS/Mammography

Treatment for late-stage breast cancer
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm340704.htm

For patient information from the National Cancer Institute, refer to http://www.cancer.gov/types/breast/patient/breast-treatment-pdq - section/all

For a 2015 review of American Cancer Society guidelines and current issues in cancer screening refer to Smith RA, Manassaram-Baptiste D, Brooks D, Doroshenk M, Fedewa S, Saslow D, et al. Cancer screening in the United States, 2015: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin 2015;65:30-54.

For more information on invasive cancer and survival refer to http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6409a1.htm?s_cid=mm6409a1_x

For current information on hereditary caner syndromes and risk assessment refer to Hereditary cancer syndromes and risk assessment. Committee Opinion No. 634. American College of Obstetricians and Gynecologists. Obstet Gynecol 2015;125:1538-43.

For the National Institute for Health and Care Excellence guidelines for cancer recognition and referral go to http://www.nice.org.uk/guidance/NG12/chapter/1-recommendations.

For the American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline refer to http://jco.ascopubs.org/content/early/2015/12/07/JCO.2015.64.3809.full

For current information on the use of vaginal estrogen in women with a history of estrogen-dependent breast cancer, refer to The use of vaginal estrogen in women with a history of estrogen-dependent breast cancer. Committee Opinion No. 659. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;127:e93-6.

For recommendations regarding aromatase inhibitors in GYN practice, refer to Aromatase inhibitors in gynecologic practice. Committee Opinion No. 663. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;127:e170-4.

For recommendations regarding benign breast disease, refer to Diagnosis and management of benign breast disorders. Practice Bulletin No. 164. American College of Obstetricians and Gynecologists. Obstet Gynecol 2016;127:e141-56.

 




Editor
Russell R. Snyder, MD

Associate Editor
Gretchen M. Lentz, MD

Past Editor
Raul Artal, MD

ISSN 1536-3619
Published 6 times per year